personalized medicine Archives
E-records shed light on drug response
Mar. 31, 2014—Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response.
Transplant drug added to PREDICT program
Aug. 15, 2013—Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection.
Recruitments bolster personalized medicine initiative
Mar. 14, 2013—VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools.
Zeppos reflects on first five years as chancellor
Mar. 1, 2013—The One Vanderbilt transformation continues as Nicholas S. Zeppos marks five years as chancellor. Read the story and watch video of Zeppos discussing the opportunities and challenges facing Vanderbilt today.
AAMC meet highlights need for research funds
Sep. 27, 2012—During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research.
Personalized medicine focus of Chancellor’s Lecture
Sep. 6, 2012—The first Chancellor’s Lecture of the academic year, entitled “Genomes, Hype and a Realistic Pathway to Personalized Medicine,” will be given Wednesday, Sept. 12, by Dan Roden, M.D., assistant vice chancellor for Personalized Medicine at Vanderbilt University.
Vanderbilt identifies genes linked to breast cancer chemo resistance
Jun. 11, 2012—A study led by Vanderbilt-Ingram Cancer Center investigators has identified a gene expression pattern that may explain why chemotherapy prior to surgery isn’t effective against some tumors and suggests new therapy options for patients with specific subtypes of breast cancer.
Vanderbilt doctors to screen patients taking statins for genetic risk factors
Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
Vanderbilt: Laboratory for health care reform
Apr. 15, 2011—Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science and clinical medicine to the solution of critical problems in patient care. Bedside checklists and electronic “dashboards” developed at Vanderbilt, for example, enable doctors and nurses to chart in exquisite...
Vanderbilt-Ingram Cancer Center launches online genetic research tool
Mar. 3, 2011—A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials.
Video: Personalized Medicine and the Future of Health Care
Sep. 30, 2010—Watch video of a Sept. 29, 2010, Lunch and Learn Event with Dr. Jeff Balser, vice chancellor for health affairs, Vanderbilt University Medical Center. Too often, physicians must base life-and-death decisions not on how an individual will respond to therapy but instead on how large groups of patients did — on average — under similar...
